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An early version of these remarks was presented in San Francisco
onMarch 30, 2010, when there was worry that Charlie might be
unable to travel for the meeting in early November.
I am deeply honored and gratified to present the McKu-
sick Leadership Award of the ASHG to Charles Epstein at
this occasion. I have known Charles as a close friend and
colleague for almost 50 years when, in 1963, he joined
our relatively new Division of Medical Genetics at the
University of Washington for a postdoctoral fellowship.
Charlie became a widely admired medical geneticist
whose achievements fit perfectly the specifications for
this award. He fostered and enriched the development of
various medical genetics disciplines and exemplified
enduring leadership and farsighted vision that ensured
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The Ameriassimilated into the broader context of science, medicine,
and health. His multiple contributions to the under-
standing of human genetics by policy makers have been
an additional important contribution.
Charlie contributed both to clinical genetics as well as to
research genetics, and he became a model for physician-
scientists. He forged and molded the specialty of human
and medical genetics in many ways and thereby helped
to create an essential place for our specialty in the basic
and clinical medical sciences.
Charlie’s undergraduate degree was in chemistry, and
early in his career he spent some time at the NIH in
Bethesda in Christian Anfinsen’s laboratory, where he
worked on protein chemistry and contributed to the
body of work that brought the Nobel Prize to Anfinsen
for showing that the three-dimensional structure of
a protein was determined by the linear sequence of its
amino acids.
During his fellowship in Seattle, Charles became inter-
ested in the recessive disease of Werner syndrome, suggest-
ing its phenotype of premature aging as a potential model
to study normal human aging. The condition was later
shown to be caused by a mutant helicase, but the mecha-
nism that produced the Werner syndrome phenotype
and the role of this helicase in normal aging remains
unknown. In fact, Charlie considers the Werner syndrome
phenotype a caricature rather than a model of aging,
but note that research on Werner syndrome continues
elsewhere.
Charles’ major research studies relate to Down syndrome
and explain the mechanism of the human Down pheno-
type to the triplication of chromosome 21. Charlie and
his colleagues were able to breed mice with segmental
trisomy 16, which shared many genes identical to those
triplicated on human chromosome 21 for gene dosage
studies. He was able to use trisomy segmental chromosome
16 mice for understanding the human trisomy 21 pheno-
type. His wife, Lois, a physician-scientist, was an important
collaborator in Charles’ work on the mouse genetic model
and much other work.
Note that, in 1986, when chromosomal abnormalities
could be increasingly diagnosed, Charlie published amajor
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chromosomal imbalance. In addition to a research and
diagnostic laboratory at the University of California in
San Francisco, Charlie initiated a genetic clinic and estab-
lished satellite clinics to bring genetic services and genetic
counseling to outlying communities. Over 50 fellows and
a large number of genetic counselors were trained.
In 2004, he, Bob Erickson, and Tony Wynshaw-Boris
published a book on inborn errors of development.1 This
book was selected as the best book in clinical medicine
by the American Association of Publishers. Between the
years of 1987 and 1993, Charles was a superb principal
editor of the AJHG, setting high standards and an example
for his successors as editors of this prestigious journal.
Charles played an important role in setting wise policies
for the ASHG, the American Board of Medical Genetics,
and the American College of Medical Genetics, and was
elected as president of all three bodies. As an important
figure and symbol of human genetics as editor of the
AJHG, Charles was attacked by the Unabomber in 1993
and almost died, but was left with residual damage in
one extremity.
I know I speak for all human and medical geneticists at
this meeting and elsewhere in telling you how much we
respect, revere, and love you not only for your achieve-
ments in human genetics but for being a real ‘‘Mensch.’’
We will now hear from Charlie about his reaction to this
well-deserved award.Address by Charles J. Epstein
November 4, 2010
Thank you very much, Arno, for your very kind intro-
duction. I am greatly honored to receive the Victor
McKusick Leadership Award of The American Society of
Human Genetics and to share the platform with this after-
noon’s two other awardees, Gerald Fink, who just received
the Gruber Genetics Prize, and Jurg Ott, the recipient of the
Society’s William Allan Award.
Victor McKusick, for whom my award is named and
himself the 2008 awardee, and Arno Motulsky, who just
introduced me and is the 2009 awardee, are generally
regarded as the fathers of medical genetics in America.
They transformed their interests in genetic diseases from
being just sidelines of their medical specialties, cardiology
and hematology, respectively, into what we recognize as
medical genetics as we have come to know it. That they
were able to do so came from the fortuitous convergence
of their own visions of how genetics could be integrated
into the practice of medicine and the explosion in scien-
tific knowledge, both conceptual and technical, that were
occurring at the time. Remember, those were days of the
Watson-Crick model for the structure of DNA, of Jacob
and Monod’s theory of genetic regulation, of Tjio and
Levan’s elucidation of the true number of human chromo-
somes, of the discovery of several human disorders caused
by aneuploidy, of the deciphering of the genetic code, and270 The American Journal of Human Genetics 88, 269–272, March 1of the development of techniques for chromosome identi-
fication, paper electrophoresis, and column chromatog-
raphy, just to mention just a few. Those were very heady
times in science, and I was so fortunate to be starting my
scientific career at that time.
My early career was blessed with the opportunity to
work with many leaders in medicine and science, but
two were the most influential. One, of course, was Arno
Motulsky, from whom I learned how genetics and medi-
cine intersected and what genetic counseling was and
how it was conducted. In those days, genetic counseling
was something that physicians and perhaps an occasional
social worker did, a situation that was soon to change.
My time with Arno was all too brief—less than a year—
but his imprint on me was indelible! We accomplished
a lot together, particularly on the elucidation of the clinical
phenotype, pathology, and genetics of Werner syndrome2
and on the first description of the fibrillin 2 disorder now
known as congenital contractural arachnodactyly.3
My other mentor was Christian Anfinsen, a protein
biochemist at the National Institutes of Health who won
the Nobel Prize in Chemistry in 1972. I worked in Chris’s
laboratory for several years, with a year out in the middle
to go to Seattle to study with Arno Motulsky. Anfinsen
was interested in the problem of how the primary amino
acid sequence of a protein determined its three-dimen-
sional or tertiary structure. The first step in attacking this
problem was to prove that it actually did, and it fell to
me to carry out a series of experiments along these lines.
It was while working on this problem that my nascent
interest in human genetics was solidified. I say ‘‘nascent’’
because my initial interest in genetics was fostered by
Kurt Benirschke, my pathology instructor in medical
school. It was Kurt, who was very interested in cytoge-
netics, who called my attention to the report of Lejeune,
Gautier, and Turpin describing the discovery of trisomy
21 as the cause of Down syndrome.4 In any event, I saw
the determination of the tertiary structures of proteins as
a genetic matter, since it was the primary structures, the
amino acid sequences, that were encoded in the genes.
I articulated this thinking in one of my earliest papers,
along with Bob Goldberger and Chris Anfinsen, entitled
The genetic control of tertiary protein structure, of which I
am still quite proud.5
Although Chris Anfinsen was a consummate experimen-
talist and seemed to be able tomake anything in the labora-
tory work, his method of teaching was by not teaching.
‘‘This iswhat Iwant you todo,’’ he said shortly after I arrived
in his laboratory, and he then promptly left town and
was gone for more than two months. After a brief period
of helplessness, it became apparent that I had to figure out
what needed to be done and how to do it by myself. It
was an important lesson and became the model that I tried
to use withmy own postdoctoral trainees—encourage indi-
vidual initiative and allow the trainee the pleasure of
making his or her own discoveries. And, the more that I
think about it, Arno employed the same strategy himself.1, 2011
The danger of this approach is that some may fall by the
wayside, but most of them did rise to the challenge.
Although I do not consider Victor McKusick as a mentor
per se, I should mention, since this is the McKusick Award
that I am receiving, that I did spend a very pleasurable half-
day a week attending his Genetics Clinic conferences at
Johns Hopkins while I was completing my time at the
NIH. Given Victor’s interests in connective tissue disor-
ders—he had just published the third edition of his
Heritable Disorders of the Connective Tissue6—I was able to
broaden my clinical exposure to this group of conditions,
as well as to many other rare entities that showed up in
his clinic. I learned a lot about the lumping and splitting
of genetic disorders, an argument that I believe has been
put to rest by the discovery of the molecular bases of these
conditions, which forms the subject matter of Inborn Errors
of Development,1 which I recently edited with Bob Erickson,
a former research fellow, and Tony Wynshaw-Boris, my
successor at UCSF.
Over the more than forty years that I worked at the NIH
and the University of California, I was extremely fortunate
to have been associated with a large group of research
fellows, some fifty in all, many of whom have gone on to
have spectacular careers in research. Although I was offi-
cially their mentor, I believe that in many ways they
were thementors and I was the student. I learned a tremen-
dous amount from them, and they certainly kept me on
my toes. I also interacted with another eighty or so clinical
trainees who came through our program, and again I
learned much from them about clinical genetics.
In the program for this meeting there is a statement that
I ‘‘helped establish and legitimize the profession of genetic
counseling in the late 1970s,’’ and later on there is refer-
ence to my ‘‘gracious leadership of our professional com-
munity.in the mid-90s.’’ What are these all about? The
first statement refers, I believe, to my involvement with
the Genetic Counseling Program at the University of Cali-
fornia, Berkeley. This program was started in 1974, about
five years after the Sarah Lawrence program began, and
ceased operation in 2004. The UCSF Genetics Clinic served
as the principal clinical training site for the Berkeley
program throughout this entire time, and over a hundred
counselors received training with us. In addition, we
always had several genetic counselors working in our
general, prenatal diagnosis, biochemical genetics, and
satellite clinics, and one of these counselors was dedicated
to the supervision of the Berkeley students. Our operating
philosophy was that genetic counselors worked with rather
than for the physician geneticists in the group, and there is
no question that these clinics could not function without
them. If any of this constitutes establishing and legiti-
mizing genetic counseling, so be it, and I am very pleased
to accept the accolade.
Now, what about my ‘‘gracious leadership in the mid-
’90s’’? This story begins thirty years ago when the
American Board of Medical Genetics was spun off by The
American Society of Human Genetics to deal with issuesThe Ameriof training and competence in various aspects of clinical
and laboratory genetics, including genetic counseling.
The Board issued its first certifications in 1982, and then
every two or three years thereafter. Unfortunately,
although these certifications had credibility within the
medical genetics community and served to upgrade the
training and qualifications of geneticists and counselors,
they had no standing outside of it. To the outside world
of the AMA and its various affiliated organizations, we
were a ‘‘self-designated board,’’ one of some 100 to 150
certifying organizations, most of dubious merit. The only
way for a certifying board to be regarded as legitimate is
for it to be accredited by the American Board of Medical
Specialties (ABMS for short), which was notoriously refrac-
tory to accepting new boards into the fold of organized
medicine. Although unsuccessful attempts to gain entry
into ABMS were made in the latter part of the 1980s,
a window of opportunity opened up in 1991 and the
American Board of Medical Genetics slipped in. It was
the 24th primary board to be accepted and now, nearly
twenty years later, it is still the last. But, this victory was
not without its costs. As far as ABMS was concerned, its
member specialty boards were supposed to be in the
business of certifying physicians—and only physicians.
PhDs and genetic counselors with master’s degrees were
not welcome. Through considerable negotiation, it was
possible to keep the certification of PhDs within the Board
of Medical Genetics—a not insignificant accomplishment,
but the ABMS was intransigent when it came to genetic
counselors, who did not possess a doctoral degree. It is
not clear why this was so, since the American Board of
Radiology was permitted to certify Radiologic Physicists
who held either PhDs or master’s degrees.7
Now, this is where the ‘‘gracious’’ part comes in. As the
then President of the Board, it fell to me to go to persuade
the diplomates that it was in the best interests of all to
split the Board into two separate boards, one comprised
of the MDs and PhDs that would be recognized by
ABMS, and the other, for the genetic counselors, that
would not. This persuasion consisted of an editorial in
The American Journal of Human Genetics, of which I was
then the Editor, and of an open forum at the annual
meeting of The American Society of Human Genetics,
which I was obliged to lead, at which the proposal was dis-
cussed. It was not a very comfortable place for me to be.
Being split off from the Board of Medical Genetics would
be a bitter pill for the counselors to swallow, and many
dire consequences of the separation were predicted.
However, it would have been even worse if the Board was
not split and remained outside of ABMS. As I wrote in
the 1992 editorial, we had been given the rare opportunity
to become a recognized and legitimate medical specialty,
with all that that entailed, and this opportunity was not
likely to come again.8 The times were tense, and indeed
everyone, not only I, had to be gracious to prevent a frac-
turing of themedical genetics community and the creation
of adversarial relationships that would indeed have beencan Journal of Human Genetics 88, 269–272, March 11, 2011 271
disastrous. A two-thirds majority of the diplomates was
required to approve the split, and the genetic counselors
comprised nearly 40% of the diplomates.9 But graciousness
did prevail, and the Board was split. Now, nearly twenty
years later, the American Board of Genetic Counseling,
the National Society of Genetic Counselors (NSGC)—the
counselors’ equivalent of the American College of Medical
Genetics—and the genetic counseling community in
general are thriving, and what happened in the ’90s is
just ancient history.
There is a certain irony in thinking about the many lead-
ership positions in human genetics that I have held. My
training in college was in chemistry, my postdoctoral
work—the time I spent at the NIH—was in protein
biochemistry, and my research at the University of Califor-
nia was on early embryonic development, X chromosome
inactivation, mouse models of Down syndrome, the super-
oxide dismutases, and the role of oxygen free radicals in
aging. All of this, I would submit, was pretty hard science.
By contrast, my clinical training in genetics was quite
modest and would be considered inadequate by current
standards. I was largely self-trained, with the help of our
many trainees and counselors and of the two outstanding
dysmorphologists in our group, Bryan Hall and Mahin
Golabi. As a result, despitemy administrative responsibility
for the operation of the UCSF Genetics Clinic and our clin-
ical trainingprogram, Imust confess that I never considered
myself as a real clinical geneticist. So, what leadership
positions was I given? President of the American Board
of Medical Genetics, President of the American College
of Medical Genetics, and Chairman of the Residency
Review Committee for Medical Genetics—the three major
elements of the clinical genetics establishment, and I have
never regretted aminute of my service to any of these orga-
nizations. Thank you all for giving me the opportunity!
I made passing mention earlier of the book, Inborn
Errors of Development, but I did not mention its subtitle:
The Molecular Basis of Clinical Disorders of Morphogenesis.
For me, this book represents the ultimate coming together272 The American Journal of Human Genetics 88, 269–272, March 1of the basic science with the clinical, of developmental
genetics with dysmorphology. Although I had long
dreamed of writing such a book, it was not until recently
that it became possible to do so – not by myself but with
two coeditors and some 400 contributors. The science is
finally catching up to the clinic.
In closing, I would like once again to thank The Amer-
ican Society of Human Genetics for awarding me this
recognition, all of you for your support, and my wife,
Dr. Lois Epstein, and our children and their families, for
all of their love and support during good times and bad.
I have been truly blessed!References
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